Oral administration of eicosapentaenoic acid or docosahexaenoic acid modifies cardiac function and ameliorates congestive heart failure in male Rats

Journal of Nutrition

Volumn 144, Issue 4, 2014, Pages 467-474

  Yamanushi, Tomoko T ^a   Kabuto, Hideaki ^a   Hirakawa, Eiichiro ^a   Janjua, Najma ^a   Takayama, Fusako ^b   Mankura, Mitsumasa ^b  

^a KAGAWA PREFECTURAL UNIVERSITY OF HEALTH SCIENCES   (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN CONVERTING ENZYME 2; ARACHIDONIC ACID; DOCOSAHEXAENOIC ACID; ENDOTHELIN 1; ICOSAPENTAENOIC ACID; MONOCROTALINE; PROSTAGLANDIN SYNTHASE; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL INFILTRATION; CLINICAL ASSESSMENT; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DRUG EFFECT; ELECTROCARDIOGRAM; GENE EXPRESSION; HEART FUNCTION; HEART RIGHT VENTRICLE; HEART WEIGHT; LIPID COMPOSITION; MALE; MONONUCLEAR CELL; MUSCLE CELL; NONHUMAN; QT INTERVAL; RAT;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DIETARY SUPPLEMENTS; DISEASE MODELS, ANIMAL; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; ELECTROCARDIOGRAPHY; HEART FAILURE; HEART VENTRICLES; LEUKOCYTES, MONONUCLEAR; MALE; ORGAN SIZE; RATS; RATS, SPRAGUE-DAWLEY; SURVIVAL ANALYSIS; VENTRICULAR DYSFUNCTION, RIGHT;

EID: 84896452245     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.3945/jn.113.175125     Document Type: Article

References (48)

1. De Caterina R. n-3 Fatty acids in cardiovascular disease. N Engl J Med. 2011;364:2439-50.
2. Bang HO, Dyerberg J, Nielsen AB. Plasma lipid and lipoprotein pattern in Greenlandic West-coast Eskimos. Lancet. 1971;1:1143-5.
3. London B, Albert C, Anderson ME, Giles WR, Van Wagoner DR, Balk E, Billman GE, Chung M, Lands W, Leaf A, et al. Omega-3 fatty acids and cardiac arrhythmias: prior studies and recommendations for future research: a report from the National Heart, Lung, and Blood Institute and Office of Dietary Supplements Omega-3 Fatty Acids and their Role in Cardiac Arrhythmogenesis Workshop. Circulation. 2007;116: e320-35.
4. Wang C, Harris WS, Chung M, Lichtenstein AH, Balk EM, Kupelnick B, Jordan HS, Lau J. n-3 Fatty acids from fish or fish-oil supplements, but not alpha-linolenic acid, benefit cardiovascular disease outcomes in primary-and secondary-prevention studies: a systematic review. Am J Clin Nutr. 2006;84:5-17.
5. von Schacky C, Harris WS. Cardiovascular benefits of omega-3 fatty acids. Cardiovasc Res. 2007;73:310-5.
6. Ezaki O, Miyake Y, Sato S, Iso H. Dietary Reference Intakes for Japanese 2010: Fat. J Nutr Sci Vitaminol. 2013;59:S44-S52.
7. Zampolli A, Bysted A, Leth T, Mortensen A, De Caterina R, Falk E. Contrasting effect of fish oil supplementation on the development of atherosclerosis in murine models. Atherosclerosis. 2006;184:78-85.
8. Lepran I, Nemecz G, Koltai M, Szekeres L. Effect of a linoleic acid-rich diet on the acute phase of coronary occlusion in conscious rats: influence of indomethacin and aspirin. J Cardiovasc Pharmacol. 1981;3:847-53.
9. Charnock JS, Mclennan PL, Abeywardena MY. Dietary modulation of lipid metabolism and mechanical performance of the heart. Mol Cell Biochem. 1992;116:19-25.
10. Mclennan PL, Abeywardena MY, Charnock JS. Influence of dietary lipids on arrhythmias and infarction after coronary artery ligation in rats. Can J Physiol Pharmacol. 1985;63:1411-7.
11. Hock CE, Beck LD, Bodine RC, Reibel DK. Influence of dietary n-3 fatty acids on myocardial ischemia and reperfusion. Am J Physiol. 1990;259:H1518-26.
12. Mclennan PL. Relative effects of dietary saturated, monounsaturated, and polyunsaturated fatty acids on cardiac arrhythmias in rats. Am J Clin Nutr. 1993;57:207-12.
13. Anderson KE, Du XJ, Sinclair AJ, Woodcock EA, Dart AM. Dietary fish oil prevents reperfusion Ins(1,4,5)P3 release in rat heart: possible antiarrhythmic mechanism. Am J Physiol. 1996;271:H1483-90.
14. Charnock JS, Mclennan PL, Abeywardena MY, Dryden WF. Diet and cardiac arrhythmia: effects of lipids on age-related changes in myocardial function in the rat. Ann Nutr Metab. 1985;29:306-18.
15. Yang B, Saldeen TG, Nichols WW, Mehta JL. Dietary fish oil supplementation attenuates myocardial dysfunction and injury caused by global ischemia and reperfusion in isolated rat hearts. J Nutr. 1993;123:2067-74.
16. Leifert WR, Dorian CL, Jahangiri A, Mcmurchie EJ. Dietary fish oil prevents asynchronous contractility and alters Ca(2+) handling in adult rat cardiomyocytes. J Nutr Biochem. 2001;12:365-76.
17. Pepe S, Mclennan PL. Cardiac membrane fatty acid composition modulates myocardial oxygen consumption and postischemic recovery of contractile function. Circulation. 2002;105:2303-8.
18. Shimada Y, Sugihara A, Tominaga Y. Enzymatic purification of polyunsaturated fatty acids. J Biosci Bioeng. 2001;91:529-38.
19. MansourMP. Reversed-phase high-performance liquid chromatography purification of methyl esters of C(16)-C(28) polyunsaturated fatty acids in microalgae, including octacosaoctaenoic acid [28:8(n-3)]. J Chromatogr A. 2005;1097:54-8.
20. Opie LH. Heart physiology from cell to circulation. 4th ed. Philadelphia: Lippincott Williams & Wilkins; 2004.
21. Kay JM, Harris P, Heath D. Pulmonary hypertension produced in rats by ingestion of Crotalaria spectabilis seeds. Thorax. 1967;22: 176-9
22. Campian ME, Hardziyenka M, de Bruin K, van Eck-Smit BL, de Bakker JM, Verberne HJ, Tan HL Early inflammatory response during the development of right ventricular heart failure in a rat model. Eur J Heart Fail. 2010;12:653-8.
23. Handoko ML, de Man FS, Happe CM, Schalij I, Musters RJ, Westerhof N, Postmus PE, Paulus WJ, van der Laarse WJ, Vonk-Noordegraaf A. Opposite effects of training in rats with stable and progressive pulmonary hypertension. Circulation. 2009;120:42-9.
24. Gomez-Arroyo JG, Farkas L, Alhussaini AA, Farkas D, Kraskauskas D, Voelkel NF, Bogaard HJ. The monocrotaline model of pulmonary hypertension in perspective. Am J Physiol Lung Cell Mol Physiol. 2012;302:L363-9.
25. Ariel A, Serhan CN. Resolvins and protectins in the termination program of acute inflammation. Trends Immunol. 2007;28:176-83.
26. Lee JK, Kodama I, Honjo H, Anno T, Kamiya K, Toyama J. Stagedependent changes in membrane currents in rats with monocrotalineinduced right ventricular hypertrophy. Am J Physiol. 1997;272:H2833-42.
27. Kuwahara M, Sugano S, Yayou K, Tsubone H, Kobayashi H. Evaluation of a new tail-cuffmethod for blood pressure measurements in rats with special reference to the effects of ambient temperature. Exp Anim. 1991;40:331-6.
28. Bazett HC. An analysis of the time-relations of electrocardiograms. Heart. 1920;7:353-70.
29. Folch J, Lees M, Stanley GHS. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem. 1957;226:497-509.
30. Kumar V, Abbas AK, Aster JC, Fausto N. Robbins & Cotran pathologic basis of disease. 8th ed. Philadelphia: Saunders Elsevier; 2009.
31. Liu L, Liu H, Visner G, Fletcher BS. Sleeping beauty-mediated eNOS gene therapy attenuates monocrotaline-induced pulmonary hypertension in rats. FASEB J. 2006;20:2594-6.
32. Uzzaman M, Honjo H, Takagishi Y, Emdad L, Magee AI, Severs NJ, Kodama I. Remodeling of gap junctional coupling in hypertrophied right ventricles of rats with monocrotaline-induced pulmonary hypertension. Circ Res. 2000;86:871-8.
33. Akhavein F, St-Michel EJ, Seifert E, Rohlicek CV. Decreased left ventricular function, myocarditis, and coronary arteriolar medial thickening following monocrotaline administration in adult rats. J Appl Physiol. 2007;103:287-95.
34. Leaf A, Xiao YF, Kang JX, Billman GE. Membrane effects of the n-3 fish oil fatty acids, which prevent fatal ventricular arrhythmias. J Membr Biol. 2005;206:129-39.
35. Ma DW, Seo J, Davidson LA, Callaway ES, Fan YY, Lupton JR, Chapkin RS. n-3 PUFA alter caveolae lipid composition and resident protein localization in mouse colon. FASEB J. 2004;18:1040-2.
36. Li Q, Wang M, Tan L, Wang C, Ma J, Li N, Li Y, Xu G, Li J. Docosahexaenoic acid changes lipid composition and interleukin-2 receptor signaling in membrane rafts. J Lipid Res. 2005;46:1904-13.
37. Ma DW, Seo J, Switzer KC, Fan YY, Mcmurray DN, Lupton JR, Chapkin RS. n-3 PUFA and membrane microdomains: a new frontier in bioactive lipid research. J Nutr Biochem. 2004;15:700-6.
38. Zaza A. Control of the cardiac action potential: the role of repolarization dynamics. J Mol Cell Cardiol. 2010;48:106-11.
39. Rupp H, Wagner D, Rupp T, Schulte LM, Maisch B. Risk stratification by the "EPA+DHA level" and the "EPA/AA ratio" focus on anti-inflammatory and antiarrhythmogenic effects of long-chain omega-3 fatty acids. Herz. 2004;29:673-85.
40. Yokoyama M, Origasa H, Matsuzaki M, Matsuzawa Y, Saito Y, Ishikawa Y, Oikawa S, Sasaki J, Hishida H, Itakura H, et al. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet. 2007;369:1090-8.
41. Matsuzaki M, Yokoyama M, Saito Y, Origasa H, Ishikawa Y, Oikawa S, Sasaki J, Hishida H, Itakura H, Kita T, et al. Incremental effects of eicosapentaenoic acid on cardiovascular events in statin-treated patients with coronary artery disease. Circ J. 2009;73:1283-90.
42. Massaro M, Habib A, Lubrano L, Del Turco S, Lazzerini G, Bourcier T, Weksler BB, De Caterina R. The omega-3 fatty acid docosahexaenoate attenuates endothelial cyclooxygenase-2 induction through both NADP (H) oxidase and PKC epsilon inhibition. Proc Natl Acad Sci USA. 2006;103:15184-9.
43. Spector AA, Kaduce TL, Figard PH, Norton KC, Hoak JC, Czervionke RL. Eicosapentaenoic acid and prostacyclin production by cultured human endothelial cells. J Lipid Res. 1983;24:1595-604.
44. Vergroesen AJ, Craford M, editors. The role of fats in human nutrition. New York: Academic Press; 1989.
45. Shimojo N, Jesmin S, Zaedi S, Soma M, Maeda S, Yamaguchi I, Goto K, Miyauchi T. Changes in important apoptosis-related molecules in the endothelin-1-induced hypertrophied cardiomyocytes: effect of the pretreatment with eicosapentaenoic acid. Exp Biol Med (Maywood). 2006;231:932-6.
46. Shimojo N, Jesmin S, Zaedi S, Soma M, Kobayashi T, Maeda S, Yamaguchi I, Goto K, Miyauchi T. EPA effect on NOS gene expression and on NO level in endothelin-1-induced hypertrophied cardiomyocytes. Exp Biol Med (Maywood). 2006;231:913-8.
47. Shimojo N, Jesmin S, Zaedi S, Maeda S, Soma M, Aonuma K, Yamaguchi I, Miyauchi T. Eicosapentaenoic acid prevents endothelin-1-induced cardiomyocyte hypertrophy in vitro through the suppression of TGF-beta 1 and phosphorylated JNK. Am J Physiol Heart Circ Physiol. 2006;291:H835-45.
48. Morin C, Fortin S, Rousseau E. Docosahexaenoic acid monoacylglyceride decreases endothelin-1-induced Ca(2+) sensitivity and proliferation in human pulmonary arteries. Am J Hypertens. 2012;25:756-63.